Vaginal Rejuvenation Market
Vaginal Rejuvenation Market By Treatment Type (Reconstructive, Functional, Cosmetic), By End-User (Hospitals, Clinics, Others) & By Region (North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan) - Global Market insights 2022 to 2032
Analysis of Vaginal Rejuvenation Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Vaginal Rejuvenation Market Outlook (2022 to 2032)
Beauty is a very important aspect and the desire for beauty enhancement is not limited to the face anymore. The vaginal transformation procedure mainly focuses on the improvement of the cosmetic appearance and tightening of the vagina to enhance sexual function. According to the American Society for Aesthetic Plastic Surgery, vaginal reconstruction is highly popular and is the latest cosmetic trend in the cosmetic and beauty market. The demand for vaginal rejuvenation is high.
The most popular procedure to remove the vaginal canal among these, particularly after childbirth, is vaginoplasty. Because there are more and more problems affecting the genital region, labiaplasty is another surgery that is frequently performed. About 12, 756 surgeries were performed in 2018, with one costing more than $53 million, according to the American Society for Aesthetic Plastic Surgery (ASAPS). In addition, the ASAPS forecasts a 53% rise in labiaplasties over the previous five years.
The global market for vaginal rejuvenation is expected to register growth with a CAGR of 13.1% over the forecast period. The market is further anticipated to reach USD 5.82 Billion by 2032 from the present value of USD 1.70 billion in 2022. The increasing popularity of vaginal reconstruction and the commercialization & marketing of vaginal procedures are among the factors likely to boost the market.
| Report Attributes | Details |
|---|---|
| Market size (2022 A) | USD 1.70 billion |
| Base Year for Estimation | 2022 |
| Forecast duration for this research | 2022 to 2032 |
| Forecasted Market value (2032 F) | USD 5.82 Billion |
| Global Market Growth rate (2022 to 2032 E) | CAGR of 13.1% |
| Key Companies Profiled | Almirall; Viveve Medical; Fotona; Hologic. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why vaginal rejuvenation is in demand?
Revolutionary developments in the cosmetic and beauty industry increase the desire for body enhancement in women. The increasing popularity of vaginal transformation is gaining attention worldwide. Usually, it is recommended for women whose vagina has widened due to vaginal delivery or aging. Women think that vaginal reconstruction will increase their self-confidence and comfort. Progressively, it has become a common option for women. The above-mentioned factors are boosting the demand for these procedures.
The currently available treatment options for vaginal rejuvenation are reconstructive, functional, and cosmetic. Reconstructive rejuvenation surgeries are aimed at correcting and repairing the anatomical structure of a vagina.
In these procedures, surgeons decrease the diameter of the vagina and correct the incontinence, pelvic organ prolapse, and congenitally malformed vagina. They also repair defects caused after vaginal delivery. Functional rejuvenation mainly focuses on the enhancement of sexual sensations. This is done by increasing clitoral stimulation for better sexual pleasure and the amplification of the G-spot by injecting collagen to make it more sensitive and large.
Cosmetic vaginal rejuvenation procedures are aimed at altering the appearance of the vulva and vaginal opening. These procedures include labioplasty, in which the inner labia are reduced and the unwanted fat from the mons pubis & the upper part of the labia majora is removed. In addition, the revirginization procedure is carried out to repair the hymen, and cordectomy is performed to reduce the clitoral cover.
What are the concerns related to this surgery?
Despite of rising no of rejuvenation treatments, vaginal rejuvenation surgical procedures carry the risk of complications such as scarring, infections, impaired blood supply, and the impairing of the nerve, which is likely to result in painful sexual intercourse or decrease sexual sensation. Vaginal transformation is performed by gynecologists or plastic surgeons to reduce the vaginal average diameter, mainly for sexual reasons.
Some developing countries are unaware of these technologies and, in certain countries, body enhancement is considered taboo. Moreover, vaginal rejuvenation treatments are very costly. These factors are likely to hamper the growth of this market.
Recently, there has been an increase in innovative and non-invasive procedures as opposed to traditional surgical techniques, which indicate that these techniques are the safest and most effective with few or no complications caused after surgery. However, the major concern is that there is poor scientific confirmation of the efficiency of rejuvenation procedures.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Segment wise Insights
On the basis of types, the cosmetic vaginal treatment held the maximum market share accounting for more than 60% at present in 2022. Perineoplasty is a sub-segment that is largely performed surgery in this type.
G-spot amplification, hymenoplasty, and labioplasty are also other opted surgeries that are likely to gain the fastest CAGR in the forecast period. The rising personal income is a key incentive behind women taking interest in these surgeries for enhanced sexual pleasures.
Vaginoplasty is the most opted surgery in the USA to lose the vaginal canal after childbirth. Labiaplasty is another treatment popular due to its effective results in treating issues in genital areas.
The reconstructive vaginal treatment segment is anticipated to gain the fastest growth in upcoming years owing to the rising no of patients reporting progression. The need for vaginal sensation is likely to drive demand for correcting and repairing the vaginal structure.
Based on the end-user industry, the hospital segment is dominant as there is the availability of needed infrastructure and skilled staff which is a major driver for this segment. The other specialist clinics segment is anticipated to gain the fastest CAGR in the forecast period.
Regional Outlook
The global market is segmented into North America, Latin America, Europe, and Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America is expected to be a dominant market in the global vaginal rejuvenation market, followed by Europe, due to the growth of the cosmetic and beauty market. Moreover, the rising popularity of vaginal reconstruction and the introduction of new innovative non-invasive procedures over traditional invasive surgeries is also boosting the market.
The American Society of Plastic Surgeons reported a 30% increase in the number of vaginal operation procedures in the U.S. However, the vaginal reconstruction market in the Asia Pacific excluding Japan and the Middle East & Africa (MEA) is expected to grow at a steady growth rate as there is low awareness about vaginal rebuilding procedures and body enhancement is limited to the face and few other body parts. In addition, the cost of these procedures is high, which limits the growth of the vaginal rejuvenation market in these regions.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
The medical industry is highly competitive due to being high profit. The industry players are focused on increasing precision and results to increase market reach. The growing investments in research and development in cosmetic surgeries have been encouraging the market players to offer effective solutions to gain a competitive edge in the market. The market is highly competitive and vendors are focused on the expansion of their services to generate dominance. The key industry players investing more in research and technologies in order to launch new forms of surgeries. As the market is expanding these players need the high cost of surgeries and maintenance of standards to ensure profit margins in the longer run.
Segmentation
-
By Treatment Type:
- Reconstructive
- Perineoplasty
- Vaginoplasty
- Functional
- Clitorial Unhooding
- G-Spot amplification
- Cosmetic
- Labioplasty
- Revirginization
- Hoodectomy
- Reconstructive
-
By End-User:
- Hospitals
- Clinics
- Others
-
By Region:
- North America
- Latin America
- Europe
- Asia-Pacific excluding Japan (APEJ)
- Japan
- Middle East & Africa (MEA)
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Treatment Type
- 6.2. End-User
- 7. Global Market Analysis and Forecast, By Treatment Type
- 7.1. Reconstructive
- 7.2. Functional
- 7.3. Cosmetic
- 8. Global Market Analysis and Forecast, By End-User
- 8.1. Hospitals
- 8.2. Clinics
- 8.3. Others
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. Asia Pacific
- 9.6. East Asia
- 9.7. MEA
- 10. North America Sales Analysis and Forecast, by Key Segments and Countries
- 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 16. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 17. Sales Forecast by Treatment Type and End-User for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. Almirall
- 19.2. Viveve Medical
- 19.3. Fotona
- 19.4. Hologic
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Bn Forecast by Region
Table 2: Global Market US$ Bn Forecast by Treatment Type
Table 3: Global Market US$ Bn Forecast by End-User
Table 4: North America Market US$ Bn Forecast by Country
Table 5: North America Market US$ Bn Forecast by Treatment Type
Table 6: North America Market US$ Bn Forecast by End-User
Table 7: Latin America Market US$ Bn Forecast by Country
Table 8: Latin America Market US$ Bn Forecast by Treatment Type
Table 9: Latin America Market US$ Bn Forecast by End-User
Table 10: Western Europe Market US$ Bn Forecast by Country
Table 11: Western Europe Market US$ Bn Forecast by Treatment Type
Table 12: Western Europe Market US$ Bn Forecast by End-User
Table 13: Eastern Europe Market US$ Bn Forecast by Country
Table 14: Eastern Europe Market US$ Bn Forecast by Treatment Type
Table 15: Eastern Europe Market US$ Bn Forecast by End-User
Table 16: Asia Pacific Market US$ Bn Forecast by Country
Table 17: Asia Pacific Market US$ Bn Forecast by Treatment Type
Table 18: Asia Pacific Market US$ Bn Forecast by End-User
Table 19: East Asia Market US$ Bn Forecast by Country
Table 20: East Asia Market US$ Bn Forecast by Treatment Type
Table 21: East Asia Market US$ Bn Forecast by End-User
Table 22: MEA Market US$ Bn Forecast by Country
Table 23: MEA Market US$ Bn Forecast by Treatment Type
Table 24: MEA Market US$ Bn Forecast by End-User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Region
Figure 4: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 7: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 8: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 16: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 17: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 18: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 19: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 20: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What are segments explained in this report?
Based on the Treatment Type the Market Report is Segmented as Reconstructive vaginal rejuvenation, Functional vaginal rejuvenation, Cosmetic vaginal rejuvenation, Etc.
What is the present market size in this market?
The current valuation of this market is USD 1.70 Billion in 2022.
What is anticipation for future market growth?
The market is likely to reach USD 5.82 Billion by end of 2032.
What is the rate of growth expected from this industry in the forecast period?
The global market for vaginal rejuvenation is expected to register growth with a CAGR of 13.1% over the forecast period.
Who are the key players in this market?
Almirall , Viveve Medical, Fotona , Hologic. are the key players.
Vaginal Rejuvenation Market